FC Patch Low: Metabolism Study

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Contraception
Interventions
DRUG

Gestodene/EE Patch (BAY86-5016)

21-day regimen per cycle (1 patch a week for 3 weeks followed by a 7-day patch-free period) for 3 cycles

DRUG

EE/Levonorgestrel (Microgynon, BAY86-4977)

21-day regimen per cycle (1 tablet a day for 3 weeks followed by a 7-day tablet-free period) for 3 cycles

Trial Locations (1)

10115

Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00933179 - FC Patch Low: Metabolism Study | Biotech Hunter | Biotech Hunter